Oncology Institute Inc Market Cap ($502.91 Million)
Market Cap & Net Worth: Oncology Institute Inc (TOI)
Oncology Institute Inc market cap. Oncology Institute Inc (NASDAQ:TOI) has a market capitalization of $502.91 Million ($502.91 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11797 globally and #3024 in its home market, demonstrating a 1.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncology Institute Inc's stock price $5.03 by its total outstanding shares 99982933 (99.98 Million). Also see cash flow conversion of Oncology Institute Inc for how efficiently the company converts equity into cash flow.
Oncology Institute Inc Market Cap History (2020–2026)
Oncology Institute Inc market cap history from 2020 to 2026. Data shows change from $1.08 Billion to $502.91 Million (-10.09% CAGR). Check current stock price of Oncology Institute Inc for real-time trading data and today's change.
Index Memberships
Oncology Institute Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.02% | #326 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1198 of 3165 |
Weight: Oncology Institute Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Oncology Institute Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncology Institute Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Oncology Institute Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.71x
Oncology Institute Inc's market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.08 Billion | $187.51 Million | -$14.32 Million | 5.76x | N/A |
| 2021 | $974.83 Million | $203.00 Million | -$10.93 Million | 4.80x | N/A |
| 2022 | $164.97 Million | $252.48 Million | $152.00K | 0.65x | 1085.34x |
| 2023 | $203.97 Million | $324.24 Million | -$83.07 Million | 0.63x | N/A |
| 2024 | $30.89 Million | $393.41 Million | -$64.66 Million | 0.08x | N/A |
| 2025 | $355.94 Million | $502.73 Million | -$60.61 Million | 0.71x | N/A |
Competitor Companies of TOI by Market Capitalization
Companies near Oncology Institute Inc in the global market cap rankings as of November 1, 2026. Also see Oncology Institute Inc (TOI) total assets for a full breakdown of the balance sheet.
Key companies related to Oncology Institute Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of Oncology Institute Inc (2020–2026)
Market capitalization of Oncology Institute Inc from 2020 to today. Between 2020 and today, Oncology Institute Inc's market cap moved from $1.08 Billion to $ 502.91 Million, with a yearly change of -10.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $502.91 Million | +41.29% |
| 2025 | $355.94 Million | +1052.10% |
| 2024 | $30.89 Million | -84.85% |
| 2023 | $203.97 Million | +23.64% |
| 2022 | $164.97 Million | -83.08% |
| 2021 | $974.83 Million | -9.72% |
| 2020 | $1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Oncology Institute Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $502.91 Million USD |
| MoneyControl | $502.91 Million USD |
| MarketWatch | $502.91 Million USD |
| marketcap.company | $502.91 Million USD |
| Reuters | $502.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as edu… Read more